TiumBio is a KOSDAQ listed, research driven biopharmaceutical company developing first or best in class small molecule and biologic therapeutics across women’s health, immuno-oncology and hematology. With a foundation built by experienced scientists, TiumBio advances differentiated programs supported by strong translational science, clinical validation and global development capabilities. TiumBio is actively seeking global out licensing and co development partnerships for its clinical stage assets.
Address
Seongnam-Si, Gyeonggi-doSouth Korea
